These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29547781)

  • 1. Quantitative estimation of α-PVP metabolites in urine by GC-APCI-QTOFMS with nitrogen chemiluminescence detection based on parent drug calibration.
    Mesihää S; Rasanen I; Ojanperä I
    Forensic Sci Int; 2018 May; 286():12-17. PubMed ID: 29547781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous identification and quantification of new psychoactive substances in blood by GC-APCI-QTOFMS coupled to nitrogen chemiluminescence detection without authentic reference standards.
    Ojanperä I; Mesihää S; Rasanen I; Pelander A; Ketola RA
    Anal Bioanal Chem; 2016 May; 408(13):3395-400. PubMed ID: 26968570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purity estimation of seized stimulant-type new psychoactive substances without reference standards by nitrogen chemiluminescence detection combined with GC-APCI-QTOFMS.
    Mesihää S; Rasanen I; Ojanperä I
    Forensic Sci Int; 2020 Jul; 312():110304. PubMed ID: 32387867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Estimation of 38 Illicit Psychostimulants in Blood by GC-APCI-QTOFMS with Nitrogen Chemiluminescence Detection Based on Three External Calibrators.
    Mesihää S; Rasanen I; Pelander A; Ojanperä I
    J Anal Toxicol; 2020 Mar; 44(2):163-172. PubMed ID: 31424078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a GC-APCI-QTOFMS library for new psychoactive substances and comparison to a commercial ESI library.
    Mesihää S; Ketola RA; Pelander A; Rasanen I; Ojanperä I
    Anal Bioanal Chem; 2017 Mar; 409(8):2007-2013. PubMed ID: 28005158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GC-MS analysis of the designer drug α-pyrrolidinovalerophenone and its metabolites in urine and blood in an acute poisoning case.
    Grapp M; Sauer C; Vidal C; Müller D
    Forensic Sci Int; 2016 Feb; 259():e14-9. PubMed ID: 26775198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of synthetic cathinone α-pyrrolidinovalero-phenone and its metabolite in urine using solid-phase extraction and gas chromatography-mass spectrometry.
    Cheng KW; Hsieh CM; Chen HW; Chi PC; Yang DP; Chan SH; Chen JY; Hwa HL; Fang CC; Weng TI; Chen PS
    Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8579. PubMed ID: 31502287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of the designer drug α-pyrrolidinobutiophenone (α-PBP) in humans: identification and quantification of the phase I metabolites in urine.
    Matsuta S; Shima N; Kamata H; Kakehashi H; Nakano S; Sasaki K; Kamata T; Nishioka H; Miki A; Katagi M; Zaitsu K; Sato T; Tsuchihashi H; Suzuki K
    Forensic Sci Int; 2015 Apr; 249():181-8. PubMed ID: 25703013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-PVP as an active component of herbal highs in Poland between 2013 and 2015.
    Byrska B; Stanaszek R; Zuba D
    Drug Test Anal; 2017 Aug; 9(8):1267-1274. PubMed ID: 28035764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry.
    Ojanperä IA; Heikman PK; Rasanen IJ
    Ther Drug Monit; 2011 Apr; 33(2):257-63. PubMed ID: 21240056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry.
    Tyrkkö E; Pelander A; Ketola RA; Ojanperä I
    Anal Bioanal Chem; 2013 Aug; 405(21):6697-709. PubMed ID: 23797910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Sauer C; Peters FT; Haas C; Meyer MR; Fritschi G; Maurer HH
    J Mass Spectrom; 2009 Jun; 44(6):952-64. PubMed ID: 19241365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to "Quantitative estimation of a-PVP metabolites in urine by GC-APCI-QTOFMS with nitrogen chemiluminescence detection based on parent drug calibration" [Forensic Sci. Int. 286 (2018) 12-17].
    Mesihää S; Rasanen I; Ojanperä I
    Forensic Sci Int; 2018 Jul; 288():327. PubMed ID: 29801702
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo detection of the new psychoactive substance AM-694 and its metabolites.
    Bertol E; Vaiano F; Di Milia MG; Mari F
    Forensic Sci Int; 2015 Nov; 256():21-7. PubMed ID: 26295909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis for Alpha-Pyrrolidinovalerophenone and Its 2-Oxo-PVP Metabolite in Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
    Andrenyak DM; Moody DE; Crites JM; Baumann MH
    J Anal Toxicol; 2021 Feb; 45(1):21-27. PubMed ID: 31776563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of new designer drugs and common drugs of abuse in urine by a combined targeted and untargeted LC-HR-QTOFMS approach.
    Paul M; Ippisch J; Herrmann C; Guber S; Schultis W
    Anal Bioanal Chem; 2014 Jul; 406(18):4425-41. PubMed ID: 24828977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
    Paul M; Bleicher S; Guber S; Ippisch J; Polettini A; Schultis W
    J Mass Spectrom; 2015 Nov; 50(11):1305-17. PubMed ID: 26505776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Determination of Amphetamine-Related New Psychoactive Substances in Urine by Gas Chromatography-Mass Spectrometry.
    Kim JY; Suh S; Park J; In MK
    J Anal Toxicol; 2018 Nov; 42(9):605-616. PubMed ID: 29982540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of drugs in plasma without primary reference standards by liquid chromatography-chemiluminescence nitrogen detection: application to tramadol metabolite ratios.
    Ojanperä S; Rasanen I; Sistonen J; Pelander A; Vuori E; Ojanperä I
    Ther Drug Monit; 2007 Aug; 29(4):423-8. PubMed ID: 17667796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of new designer drugs in post-mortem blood using high-resolution mass spectrometry.
    Pasin D; Bidny S; Fu S
    J Anal Toxicol; 2015 Apr; 39(3):163-71. PubMed ID: 25552261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.